(0.00%) 5 478.25 points
(-0.04%) 38 804 points
(0.04%) 19 929 points
(0.27%) $80.55
(1.22%) $2.82
(0.16%) $2 332.70
(-0.31%) $29.30
(-0.20%) $969.00
(0.02%) $0.932
(-0.14%) $10.64
(0.07%) $0.788
(-1.86%) $86.80
Live Chart Being Loaded With Signals
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network...
Stats | |
---|---|
Šios dienos apimtis | 30 224 |
Vidutinė apimtis | 158 588 |
Rinkos kapitalizacija | 26.90M |
EPS | $-0.290 ( Q1 | 2024-05-20 ) |
Kita pelno data | ( $0 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.430 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0100 (1.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Miller Victor | Sell | 25 000 | Stock Option (Right to Buy) |
2024-04-01 | Miller Victor | Buy | 25 000 | Common Stock |
2024-02-01 | Safier Jacob | Buy | 10 100 | Common Stock (par value $0.01) |
2024-01-31 | Safier Jacob | Buy | 5 000 | Common Stock (par value $0.01) |
2024-01-30 | Safier Jacob | Buy | 25 000 | Common Stock (par value $0.01) |
INSIDER POWER |
---|
93.44 |
Last 93 transactions |
Buy: 2 511 105 | Sell: 463 608 |
Orgenesis Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
NVNO | 0.899 |
VTYX | 0.883 |
LFVN | 0.882 |
SOUN | 0.865 |
ALRM | 0.861 |
RGTI | 0.861 |
FEMY | 0.859 |
OSS | 0.851 |
PHIO | 0.84 |
ICLR | 0.84 |
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Orgenesis Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $530 000 |
Bruto pelnas: | $-5.73M (-1 080.19 %) |
EPS: | $-1.910 |
FY | 2023 |
Pajamos: | $530 000 |
Bruto pelnas: | $-5.73M (-1 080.19 %) |
EPS: | $-1.910 |
FY | 2022 |
Pajamos: | $36.03M |
Bruto pelnas: | $15.59M (43.26 %) |
EPS: | $-0.480 |
FY | 2021 |
Pajamos: | $35.50M |
Bruto pelnas: | $-1.14M (-3.22 %) |
EPS: | $0.744 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Orgenesis Inc
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.